Recombinant human TSH-aided radioiodine treatment of advanced differentiated thyroid carcinoma: a single-centre study of 54 patients-Reference-Cited by-同舟云学术

Recombinant human TSH-aided radioiodine treatment of advanced differentiated thyroid carcinoma: a single-centre study of 54 patients

Published:2003-08-01 Issue:8 Volume:30 Page:1077-1086
ISSN:1619-7070
Container-title:European Journal of Nuclear Medicine and Molecular Imaging
language:
Short-container-title:European Journal of Nuclear Medicine and Molecular Imaging

Author:

Turska Maria,Jarzab Barbara,Handkiewicz-Junak Daria,Roskosz J�zef,Puch Zbigniew,Wygoda Zbigniew,Kukulska Aleksandra,Jurecka-Lubieniecka Beata,Hasse-Lazar Kornelia,Zajusz Aleksander

Publisher

Springer Science and Business Media LLC

Subject

Radiology, Nuclear Medicine and imaging,General Medicine,Radiology, Nuclear Medicine and imaging,General Medicine

Link

http://link.springer.com/content/pdf/10.1007/s00259-003-1190-5.pdf

Cited by 69 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Korean Thyroid Association Guidelines on the Management of Differentiated Thyroid Cancers; Part III. Management of Advanced Differentiated Thyroid Cancers - Chapter 3. Radioactive Iodine Therapy in Advanced Thyroid Cancer 2024;International Journal of Thyroidology;2024-05-30

2. Comparison of Recombinant Human Thyroid-Stimulating Hormone and Thyroid Hormone Withdrawal for 131I Therapy in Patients With Intermediate- to High-Risk Thyroid Cancer;Clinical Nuclear Medicine;2024-01-19

3. La modalità di preparazione a radioiodio non influenza la sopravvivenza nel carcinoma tiroideo metastatico;L'Endocrinologo;2023-02

4. Recombinant or endogenous thyroid-stimulating hormone for radioactive iodine therapy in thyroid cancer: state of knowledge and current controversies;European Journal of Endocrinology;2023-01-19

5. Effect of recombinant human thyroid stimulating hormone on long-term salivary gland dysfunction in thyroid cancer patients treated with radioactive iodine. A systematic review;Oral Oncology;2023-01